This is a discussion on Ustekinumab pipeline update June 2008 within the Specialty Drug Pipeline by Month forum, part of the New Drug Approvals and Pipeline category; Ustekinumab by Centocor, response to BLA expected 10/08 •Class/MOA: human monoclonal antibody •Use: treatment of adult patients with ...
|
|||||||
| Register | Help | Members List | Mark Forums Read |
|
||||
|
Ustekinumab by Centocor, response to BLA expected 10/08
•Class/MOA: human monoclonal antibody •Use: treatment of adult patients with chronic moderate to severe plaque psoriasis •Dosage form: SC injection •Link to press release: •Centocor Press Release 2/08•Link to clinicaltrials.gov: •Phase III safety and efficacy study in Patients With Severe Plaque-Type PsoriasisUPDATE: Though 2 Phase III studies produced positive results, animal studies demonstrated an increased tumor growth/cancer risk Drug will be reviewed by outside experts: News article 6/08 |
![]() |
| Thread Tools | |
| Display Modes | |
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| FDA update on brand drugs for June 9, 2008 | chantell.reagan | New Brand Drug Approvals by Month | 0 | 06-12-2008 02:37 PM |
| FDA update on generic drugs for June 9, 2008 | chantell.reagan | New Generic Approvals by Month | 0 | 06-12-2008 02:33 PM |
| Alogliptin pipeline update June 2008 | chantell.reagan | Non-Specialty Drug Pipeline by Month | 0 | 06-10-2008 10:33 AM |
| FDA update on brand drugs for June 3, 2008 | diana.papshev | New Brand Drug Approvals by Month | 0 | 06-06-2008 02:18 PM |
| Promacta pipeline update May 2008 | chantell.reagan | Specialty Drug Pipeline by Month | 0 | 06-03-2008 02:20 PM |